Loeillot Olivierinsider trades
In SEC Form 4 filings, Loeillot Olivier is listed as Chief Executive Officer of Repligen Corp (RGEN). In the last 90 days, Loeillot Olivier sold $5.95M of Repligen Corp (RGEN) on the open market and bought none. All 7 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RGENRepligen Corp | Chief Executive Officer | 19 | Oct 6 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-08-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RGENRepligen Corp | Oct 5 | Oct 6 | S | 1,333 | $178.75 | Sale −$238,274 | 45,788 | Yes | Form 4 |
| RGENRepligen Corp | Oct 5 | Oct 6 | M | 4,202 | $154.96 | $651,142 | 49,990 | Yes | Form 4 |
| RGENRepligen Corp | Oct 5 | Oct 6 | S | 4,202 | $190.00 | Sale −$798,380 | 45,788 | Yes | Form 4 |
| RGENRepligen Corp | Oct 5 | Oct 6 | M · derivative | 4,202 | $154.96 | $651,142 | 8,405 | Yes | Form 4 |
| RGENRepligen Corp | Oct 2 | Oct 5 | F | 1,248 | $181.70 | $226,762 | 47,121 | No | Form 4 |
| RGENRepligen Corp | Sep 24 | Sep 25 | M | 8,404 | $154.96 | $1,302,284 | 56,773 | Yes | Form 4 |
| RGENRepligen Corp | Sep 24 | Sep 25 | S | 8,404 | $190.00 | Sale −$1,596,760 | 48,369 | Yes | Form 4 |
| RGENRepligen Corp | Sep 24 | Sep 25 | M | 4,542 | $155.38 | $705,736 | 52,911 | Yes | Form 4 |
| RGENRepligen Corp | Sep 24 | Sep 25 | S | 4,542 | $190.00 | Sale −$862,980 | 48,369 | Yes | Form 4 |
| RGENRepligen Corp | Sep 24 | Sep 25 | M · derivative | 8,404 | $154.96 | $1,302,284 | 12,607 | Yes | Form 4 |
| RGENRepligen Corp | Sep 24 | Sep 25 | M · derivative | 4,542 | $155.38 | $705,736 | 9,085 | Yes | Form 4 |
| RGENRepligen Corp | Sep 21 | Sep 22 | M | 5,426 | $141.79 | $769,353 | 53,795 | Yes | Form 4 |
| RGENRepligen Corp | Sep 21 | Sep 22 | S | 5,426 | $180.00 | Sale −$976,680 | 48,369 | Yes | Form 4 |
| RGENRepligen Corp | Sep 21 | Sep 22 | M · derivative | 5,426 | $141.79 | $769,353 | 5,426 | Yes | Form 4 |
| RGENRepligen Corp | Sep 4 | Sep 8 | S | 3,035 | $165.90 | Sale −$503,507 | 48,369 | Yes | Form 4 |
| RGENRepligen Corp | Sep 3 | Sep 8 | F | 2,842 | $169.61 | $482,032 | 51,404 | Yes | Form 4 |
| RGENRepligen Corp | Aug 20 | Aug 21 | M | 5,426 | $141.79 | $769,353 | 59,672 | Yes | Form 4 |
| RGENRepligen Corp | Aug 20 | Aug 21 | S | 5,426 | $180.00 | Sale −$976,680 | 54,246 | Yes | Form 4 |
| RGENRepligen Corp | Aug 20 | Aug 21 | M · derivative | 5,426 | $141.79 | $769,353 | 10,852 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.